Walter, K. R., Ford, M. E., Gregoski, M. J., Kramer, R. M., Knight, K. D., Spruill, L., . . . Turner, D. P. (2019). Advanced glycation end products are elevated in estrogen receptor-positive breast cancer patients, alter response to therapy, and can be targeted by lifestyle intervention. Breast cancer research and treatment, 173(3), 559-571. https://doi.org/10.1007/s10549-018-4992-7
Chicago-Zitierstil (17. Ausg.)Walter, Katherine R., et al. "Advanced Glycation End Products Are Elevated in Estrogen Receptor-positive Breast Cancer Patients, Alter Response to Therapy, and Can Be Targeted by Lifestyle Intervention." Breast Cancer Research and Treatment 173, no. 3 (2019): 559-571. https://doi.org/10.1007/s10549-018-4992-7.
MLA-Zitierstil (9. Ausg.)Walter, Katherine R., et al. "Advanced Glycation End Products Are Elevated in Estrogen Receptor-positive Breast Cancer Patients, Alter Response to Therapy, and Can Be Targeted by Lifestyle Intervention." Breast Cancer Research and Treatment, vol. 173, no. 3, 2019, pp. 559-571, https://doi.org/10.1007/s10549-018-4992-7.